Search Tag: ovarian tumour detection

IMAGING Management

2025 27 Oct

  Early and reliable separation of benign, borderline and malignant ovarian tumours guides timely treatment and the choice of surgery. Ultrasound (US) is the first step in most pathways, yet readings can vary between clinicians and there are no widely confirmed criteria for borderline disease. A multi-centre project in China developed a deep learning...Read more

Women's Health

2025 27 Oct

  Early and reliable separation of benign, borderline and malignant ovarian tumours guides timely treatment and the choice of surgery. Ultrasound (US) is the first step in most pathways, yet readings can vary between clinicians and there are no widely confirmed criteria for borderline disease. A multi-centre project in China developed a deep learning...Read more

Decision Support

2025 27 Oct

  Early and reliable separation of benign, borderline and malignant ovarian tumours guides timely treatment and the choice of surgery. Ultrasound (US) is the first step in most pathways, yet readings can vary between clinicians and there are no widely confirmed criteria for borderline disease. A multi-centre project in China developed a deep learning...Read more

Artificial Intelligence

2025 27 Oct

  Early and reliable separation of benign, borderline and malignant ovarian tumours guides timely treatment and the choice of surgery. Ultrasound (US) is the first step in most pathways, yet readings can vary between clinicians and there are no widely confirmed criteria for borderline disease. A multi-centre project in China developed a deep learning...Read more

Ultrasound

2025 27 Oct

  Early and reliable separation of benign, borderline and malignant ovarian tumours guides timely treatment and the choice of surgery. Ultrasound (US) is the first step in most pathways, yet readings can vary between clinicians and there are no widely confirmed criteria for borderline disease. A multi-centre project in China developed a deep learning...Read more

Artificial Intelligence

2025 15 Aug

  Ovarian cancer remains a major global health concern, ranking as the third most common gynaecological malignancy. Outcomes vary significantly depending on the stage of diagnosis, with survival rates far lower for advanced disease. Accurate classification of ovarian lesions is therefore essential, guiding timely and appropriate treatment. While...Read more